Fundraising Fox

Good Therapeutics

acquired by Roche

Seattle, US · Founded 2016 · Delaware corporation · 2 known investors

Portfolio company acquired by Roche.

Biotechin /bonum-therapeutics

Founders & leadership

MM
Mitchell MutzDirector
NW
Nicholas WalrodDirector
JM
John MulliganExecutive Officer, Director, Promoter
KH
Karl HandelsmanDirector
JM
John McKearnDirector

Investors · 2

Digitalis VenturesNew York · $100K – $10M
RiverVest Venture PartnersSt. Louis · $500K – $3M

Reported raises · per SEC filings

Form D private placements
▶$8.8MraisedDec 2021 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Karl HandelsmanDirector
  • John MulliganExecutive Officer, Director, Promoter
  • Nicholas WalrodDirector
  • John McKearnDirector
  • Diane HollenbaughExecutive Officer
  • Monique SchiersingDirector
  • Neela PatelExecutive Officer
Offering amount
$26.4M
Amount sold
$8.8M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22.3MraisedMay 2020 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mitchell MutzDirector
  • John McKearnDirector
  • Nicholas WalrodDirector
  • John MulliganExecutive Officer, Director, Promoter
  • Karl HandelsmanDirector
Offering amount
$22.3M
Amount sold
$22.3M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.